UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort

Scientific reports, 2020-05, Vol.10 (1), p.7420-7420, Article 7420

2020

Volltextzugriff (PDF)

Semaphorin 6C Suppresses Proliferation of Pancreatic Cancer Cells via Inhibition of the AKT/GSK3/β-Catenin/Cyclin D1 Pathway

International journal of molecular sciences, 2022-02, Vol.23 (5), p.2608

2022

Volltextzugriff (PDF)

A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study

British journal of cancer, 2022-04, Vol.126 (7), p.1018-1026

2022

Volltextzugriff (PDF)

Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan

PloS one, 2020-12, Vol.15 (12), p.e0244487

2020

Volltextzugriff (PDF)

Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan

Journal of biomedical science, 2024-02, Vol.31 (1), p.21-21, Article 21

2024

Volltextzugriff (PDF)

Tissue Quality Comparison Between Heparinized Wet Suction and Dry Suction in Endoscopic Ultrasound-Fine Needle Biopsy of Solid Pancreatic Masses: A Randomized Crossover Study

Gut and Liver, 2023, 17(2), , pp.318-327

2023

Volltextzugriff (PDF)

Multicentre, phase II study of gemcitabine and S‐1 in patients with advanced biliary tract cancer: TG1308 study

Liver international, 2020-10, Vol.40 (10), p.2535-2543

2020

Volltextzugriff (PDF)

Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5‐fluorouracil and leucovorin

Journal of hepato-biliary-pancreatic sciences, 2022-06, Vol.29 (6), p.670-681

2022

Volltextzugriff (PDF)

Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer

Cancers, 2023-02, Vol.15 (4), p.1008

2023

Volltextzugriff (PDF)

Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation

Biomedical Journal, 2024-06, Vol.47 (3), p.100696, Article 100696

2024

Volltextzugriff (PDF)

Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study

Frontiers in oncology, 2022-06, Vol.12, p.800842-800842

2022

Volltextzugriff (PDF)

Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study

Therapeutic advances in medical oncology, 2021, Vol.13, p.17588359211058255-17588359211058255

2021

Volltextzugriff (PDF)

Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives

Seminars in liver disease, 2021-08, Vol.41 (3), p.263-276

2021

Volltextzugriff (PDF)

Investigation into the content of red material in EUS-guided pancreatic cancer biopsies

Gastrointestinal endoscopy, 2023-06, Vol.97 (6), p.1083-1091.e1

2023

Volltextzugriff (PDF)

Percutaneous Computed Tomography-Guided Coaxial Core Biopsy for the Diagnosis of Pancreatic Tumors

Journal of clinical medicine, 2019-10, Vol.8 (10), p.1633

2019

Volltextzugriff (PDF)

Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study

Clinical cancer research, 2022-10, Vol.28 (19), p.4248-4257

2022

Volltextzugriff (PDF)

The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study

International journal of surgery (London, England), 2023-09, Vol.109 (9), p.2614-2623

2023

Volltextzugriff (PDF)

Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2024-06, Vol.24 (4), p.600-607

2024

Volltextzugriff (PDF)

Author Correction: The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort

Scientific reports, 2020-11, Vol.10 (1), p.20199-20199, Article 20199

2020

Volltextzugriff (PDF)

The impact of UGT1A1 polymorphisms on treatment toxicities from liposomal irinotecan (PEP02, nal-IRI)

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2019-06, Vol.19, p.S111-S112

2019

Volltextzugriff (PDF)

Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma– with Emphasis on Locoregional Therapy for Oligoprogression

Liver cancer (Basel ), 2024-02, p.509-521

2024

Volltextzugriff (PDF)

JKT4-RS3. Role of liver-directed therapy for advanced hepatocellular carcinoma in the era of combination immunotherapy

Journal of Japanese Society of Gastroenterology, 2023-10, Vol.120 (suppl-2), p.A745-A745

2023

Volltextzugriff (PDF)

Tissue Quality Comparison Between Heparinized Wet Suction and Dry Suction in Endoscopic Ultrasound-Fine Needle Biopsy of Solid Pancreatic Masses: A Randomized Crossover Study

Gut and liver, 2023, Vol.17 (2), p.318

2023

Volltextzugriff (PDF)

Tissue Quality Comparison Between Heparinized Wet Suction and Dry Suction in Endoscopic Ultrasound-Fine Needle Biopsy of Solid Pancreatic Masses: A Randomized Crossover Study

Gut and liver, 2023, Vol.17 (2), p.318

2023

Volltextzugriff (PDF)

Tissue Quality Comparison Between Heparinized Wet Suction and Dry Suction in Endoscopic Ultrasound-Fine Needle Biopsy of Solid Pancreatic Masses: A Randomized Crossover Study

Gut and liver, 2023, Vol.17 (2), p.318

2023

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(107)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort

Semaphorin 6C Suppresses Proliferation of Pancreatic Cancer Cells via Inhibition of the AKT/GSK3/β-Catenin/Cyclin D1 Pathway

A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study

Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan

Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan

Tissue Quality Comparison Between Heparinized Wet Suction and Dry Suction in Endoscopic Ultrasound-Fine Needle Biopsy of Solid Pancreatic Masses: A Randomized Crossover Study

Multicentre, phase II study of gemcitabine and S‐1 in patients with advanced biliary tract cancer: TG1308 study

Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5‐fluorouracil and leucovorin

Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer

Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation

Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study

Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study

Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives

Investigation into the content of red material in EUS-guided pancreatic cancer biopsies

Percutaneous Computed Tomography-Guided Coaxial Core Biopsy for the Diagnosis of Pancreatic Tumors

Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study

The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study

Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer

Author Correction: The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort

The impact of UGT1A1 polymorphisms on treatment toxicities from liposomal irinotecan (PEP02, nal-IRI)

Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma– with Emphasis on Locoregional Therapy for Oligoprogression

JKT4-RS3. Role of liver-directed therapy for advanced hepatocellular carcinoma in the era of combination immunotherapy

Tissue Quality Comparison Between Heparinized Wet Suction and Dry Suction in Endoscopic Ultrasound-Fine Needle Biopsy of Solid Pancreatic Masses: A Randomized Crossover Study

Tissue Quality Comparison Between Heparinized Wet Suction and Dry Suction in Endoscopic Ultrasound-Fine Needle Biopsy of Solid Pancreatic Masses: A Randomized Crossover Study

Tissue Quality Comparison Between Heparinized Wet Suction and Dry Suction in Endoscopic Ultrasound-Fine Needle Biopsy of Solid Pancreatic Masses: A Randomized Crossover Study

Suchergebnisse filtern